Carbon dots modified with polydopamine (CDs/PDA), a low‐cost and environmentally friendly photothermal material, is prepared in this work. The results show that the polymerization of dopamine is significantly accelerated due to the interaction between CDs and dopamine. Importantly, the interaction also greatly promotes nonradiative recombination of photoexcited charge carriers, thereby enhancing the photothermal conversion performance of CDs/PDA. The obtained CDs/PDA composite shows superior photothermal evaporation efficiency in comparison with CDs and PDA owing to the enhanced light absorption, porous structure, and appropriate interaction. In addition, CDs/PDA exhibits excellent stability. These merits enable CDs/PDA show great promise in solar‐energy‐related applications.
A light-responsive
optical switching material is reported, which
was obtained by incorporating carbon dots (CDs) into thermochromic
hydroxypropylmethyl cellulose (HPMC). The ultrasmall size of CDs guarantees
the considerable transparency of CDs/HPMC. Under illumination, CDs/HPMC
shows rapid and reversible optical switching between transparent and
opaque states due to the remarkable photothermal effect of CDs. Moreover,
the interaction between CDs and HPMC enhances the light absorption
and boosts the nonradiative recombination of photoexcited charge carriers
that further promote the photothermal conversion of CDs, and also
ensures the structural stability of the composite. The obtained CDs/HPMC
with good reversibility and high sensitivity which can dynamically
switch their transparency in response to weather conditions exhibits
excellent solar modulation ability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.